Strategic Growth
Ratio Therapeutics Appoints Marcel Reichen as Chief Strategy Officer
Ratio Therapeutics; Marcel Reichen; Chief Strategy Officer; radiopharmaceuticals; oncology; radioligand therapy; pharmaceutical industry; cancer treatment; strategic growth; precision oncology
BeiGene Rebrands as BeOne Medicines, Emphasizing Global Unity Against Cancer
BeiGene, BeOne Medicines, Global Oncology, Cancer Treatment, Name Change, Strategic Growth